S100A14 promotes the growth and metastasis of hepatocellular carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3831-3836

  Zhao, Fu Tao ^a,b   Jia, Zhan Sheng ^b   Yang, Qun ^a   Song, Le ^a   Jiang, Xiao Jing ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Marker; Metastasis; Prognosis; S100A14

Indexed keywords

EID: 84882612530     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3831     Document Type: Article

References (19)

1. Boye K, Maelandsmo GM (2010). S100A4 and metastasis: a small actor playing many roles. Am J Pathol, 176, 528-35.
2. Bulk E, Sargin B, Krug U, et al (2009). S100A2 induces metastasis in non-small cell lung cancer. Clin Cancer Res, 15, 22-9.
3. Chen H, Yu D, Luo A, et al (2009). Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res, 69, 3451-7.
4. Chen H, Yuan Y, Zhang C, et al (2012). Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation. J Biol Chem, 287, 109-19.
5. El-Serag HB (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-73.
6. Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52.
7. Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006). Tumor mediated up-regulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol, 8, 1369-75.
8. Jin Q, Chen H, Luo A, Ding F, Liu Z (2011). S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One, 6, e19375.
9. Li P, Lin Y, Zhang Y, Zhu Z, Huo K (2013). SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med, 11, 52.
10. Li W, Tan D, Zhang Z, Liang JJ, Brown RE (2008). Activation of Akt-mTOR- p70S6K pathway in angiogenesis inhepatocellular carcinoma. Oncol Rep, 20, 713-9.
11. Lukanidin E, Sleeman JP (2012). Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol, 22, 216-25.
12. McClune AC, Tong MJ (2010). Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis, 14, 461-76.
13. Nordenstedt H, White DL, El-Serag HB (2010). The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis, 42, S206-14.
14. Sapkota D, Costea DE, Bø M, et al (2012). S100A14 inhibits proliferation of oral carcinoma derived cells through G1- arrest. Oral Oncol, 48, 219-25.
15. Tao YM, Huang JL, Zeng S, et al (2013). BTB/POZ domaincontaining protein 7: Epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology, 57, 2326-37.
16. Wang HY, Zhang JY, Cui JT, et al (2010). Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep, 23, 45-52.
17. Xue TC, Chen RX, Han D, et al (2012). Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. Exp Ther Med, 3, 117-23.
18. Yang Y, Nagano H, Ota H, et al (2007). Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery, 141, 196-202.
19. Zhou L, Liu J, Luo F (2006). Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol, 12, 1175-81.